Decrease of LFA-1 is associated with upregulation of TGF-β in CD4+ T cell clones derived from rats nasally tolerized against experimental autoimmune myasthenia gravis

Clinical Immunology and Immunopathology

Volumn 89, Issue 3, 1998, Pages 196-204

  Xiao, Bao Guo ^a   Zhang, Guang Xian ^a   Shi, Fu Dong ^a   Ma, Cun Gen ^a   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD4+ cells; EAMG; LFA 1; Nasal tolerance; TGF

Indexed keywords

CD4 ANTIGEN; CHOLINERGIC RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OKT 4; OKT 8; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; T LYMPHOCYTE ACTIVATION;

EID: 0032400510     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4537     Document Type: Article

References (40)

1. Weiner H. L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335-343.
2. Dick A. D., Cheng Y. F., Mckinnon A., Liversidge J., Forrester J. V. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. Br. J. Ophthalmol. 77:1993;171-175.
3. Ma C. G., Zhang G. X., Xiao B. G., Link J., Olsson T., Link H. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Neuroimmunol. 58:1995;51-60.
4. +. J. Immunol. 146:1989;1163-1168.
5. Javed N., Jewell S., Gienapp I., Cox K., Whitacre C. Oral tolerance in experimental autoimmune encephalomyelitis: Role of gastrointestinal lymphoid cells. FASEB J. 8:1994;A245.
6. ++. FASEB J. 8:1994;A521.
7. Drachman D. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810.
8. Asthana D., Fujii Y., Huston G., Lindstrom J. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors. Clin. Immunol. Immunopathol. 67:1993;240-248.
9. Hohlfeld R., Toyka K. V., Tzartos S. J., Carson W., Conti-Tronconi B. M. Human T helper lymphocytes in myasthenia gravis recognize the nicotinic receptor subunit. Proc. Natl. Acad. Sci. USA. 84:1987;5379-5383.
10. Link H., Olsson O., Sun J. B., Wang W. Z., Andersson G., Ekre H. P., Brenner T., Abramsky O., Olsson T. Acetylcholine receptor reactive T and B cells in myasthenia gravis and controls. J. Clin. Invest. 87:1991;2191-2196.
11. Fujii Y., Lindstrom J. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. J. Immunol. 140:1988;1830-1837.
12. Lennon V. A., McCormick D. J., Lambert E. H., Griesmann G. E., Atassi M. Z. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromusclar junction and induces experimental autoimmune myasthenia gravis, T cell immunity, and modulating autoantibodies. Proc. Natl. Acad. Sci. USA. 82:1985;8805-8809.
13. Wang Z. Y., Qiao J., Melms A., Link H. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 152:1993;394-404.
14. Christadoss P., Dauphinee M. Immunotherapy for myasthenia gravis: A murine model. J. Immunol. 136:1986;2437-2440.
15. Kaul R., Shenoy M., Goluszko E., Christadoss P. Major histocompatibility class II gene disruption prevents experimental autoimmune myasthenia gravis. J. Immunol. 152:1994;3152-3157.
16. Dole C., Strominger J. L. Interaction between CD4 and class II MHC molecules mediated cell adhesion. Nature. 330:1987;256-259.
17. +. J. Immunol. 140:1988;1745-1752.
18. Kinch M. S., Strominger J. L., Doyle C. Cell adhesion mediated by CD4 and MHC class II proteins requires active cellular processes. J. Immunol. 151:1993;4552-4561.
19. Goodall Y. K., Gamble J. R., Vadas M. A. Regulation of adhesion and adhesion molecules in endothelium by transforming growth factor-β Adhesion in Leukocyte Homing and Differentiation. 1993;Springer-Verlag, Berlin. p. 187.
20. Wang Z. Y., Qiao J., Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J. Neuroimmunol. 44:1993;209-214.
21. Lindstrom J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74:1981;432-460.
22. Deibler G. E., Martensson R. E., Kies M. V. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
23. Lennon V. A., Lambert E. H., Leiby K. R., Okarma T. B., Talib S. Recombinant human acetylcholine receptor α-subunit induces chronic experimental autoimmune myasthenia gravis. J. Immunol. 146:1991;2245-2248.
24. Link J., Söderström M., Kostulas V., Olsson T., Höjeberg B., Ljungdahl ÅA., Link H. Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-γ, interleukin-4 and transforming growth factor-β J. Neuroimmunol. 49:1994;9-18.
25. Weiner H. L., Zhang Z. J., Khoury S. J. Antigen-driven peripheral immune tolerance. Suppression of organ specific autoimmune diseases by oral administration of autoantigens. Ann. N. Y. Acad. Sci. 636:1991;227-232.
26. Springer T. A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
27. Shimizu Y., van Seventer G. A., Horgan K. J., Shaw S. Roles of adhesion molecules in T cell recognition: Fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol. Rev. 114:1990;109-143.
28. Liu Y., Linsley P. S. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:1992;265-267.
29. Wawryk S. O., Novotny J. R., Wicks I. P. The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol. Rev. 108:1989;135-161.
30. Iwamoto I., Nakao A. Induction of Th2 cell tolerance to a soluble antigen by blockade of the LFA-1-dependent pathway prevents allergic inflammation. Immunol. Res. 14:1995;263-270.
31. van Seventer G. A., Shimizu Y., Horgan K. J., Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:1990;4579-4586.
32. van Schooten W. C. A., Quan J. The influence of LFA-1 on human T cells stimulated by solid-phase immobilized HLA class II-peptide complexes. Scand. J. Immunol. 38:1993;373-380.
33. Issekutz T. B. Effect of antigen challenge on lymph node lymphocyte adhesion to vascular endothelial cells and the role of VLA-4 in the rat. Cell. Immunol. 138:1991;300-312.
34. Wysocki J., Issekutz T. B. Effect of T cell activation on lymphocyte endothelial cell adherence and the role of VLA-4 in the rat. Cell. Immunol. 140:1992;420-431.
35. Shimizu Y., Newman W., Gopal T. V. Four molecular pathways of T cell adhesion to endothelial cells: Roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J. Cell. Biol. 113:1991;1203-1212.
36. Pryce G., Male D., Campbell I., Greenwood J. Factors controlling T-cell migration across rat cerebral endotheliumin vitro. J. Neuroimmunol. 75:1997;84-94.
37. ++. J. Immunol. 155:1995;910-916.
38. Wang Z. Y., Link H., Ljungdahl ÅA., Hojeberg B., Link J., He B., Qiao J., Melms A., Olsson T. Induction of interferon-γ, interleukin-4 and transforming growth factor-β in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 157:1994;353-368.
39. Frishberg Y., Meyers C. M., Kelly C. J. Cyclosporine A regulates T cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression. Kidney Int. 50:1996;45-53.
40. Machold K. P., Carson D. A., Lotz M. Transforming growth factor-β inhibition of EBV and IL-4-induced immunoglobulin production in human B lymphocytes. J. Clin. Immunol. 13:1993;219-227.